ArticlePloS one2018

Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML).

Melanie Gentil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.